Skip to main content
All lobbying filings

THEGROUP DC, LLC

THEGROUP DC, LLC filed a Q1 report for REGENXBIO on April 20, 2026, reporting $60,000 in lobbying income.

Lobbying for REGENXBIO · Gene therapy biotechnology company.

All filings by THEGROUP DC, LLC · Everything REGENXBIO has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 20, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
Maryland

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Health Issues

Issues related to rare disease.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem